System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Sébastien Thureau is an expert in Radiotherapy at Centre Henri Becquerel (France). As of October 2026, ScienceLeadR ranks Sébastien Thureau in the top 1% of experts worldwide for Squamous Cell Carcinoma of Head and Neck, Lung Neoplasms and Thoracic Neoplasms. Sébastien Thureau has authored 231 publications, the most recent in 2026, and is an investigator in 32 clinical trials, 14 of them ongoing. SLR score: 1,239 (community average: 125). How the SLR is computed.

LeadR Profile

Sébastien Thureau Centre Henri Becquerel France
1 239 ScienceLeadR Reputation 1239

Unlock

Register Login
Network Map

Radiotherapy

Subspecialties: Oncology - Nuclear Medicine - Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2008 - 2026
Source: PubMed

Centre Henri Becquerel

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 231

Citations

Citations: 1 794 1st author: 48 Last author: 44 Unique author: 1

Main journals

Cancer Radiother 87
MED NUCL 17
HAL (Le Centre pour la Communication Scientifique Directe) 12
Radiother Oncol 10
Radiat Oncol 7

Best Journals

J Clin Oncol 3
Lancet Oncol 2
Ann Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Evaluation of the nutritional and digestive impact of irradiation in nasopharyngeal cancers: the French multicenter retrospective DRAKAR study.
PMID 42892922 — radiotherapy, hospitalization, malnutrition, neoplasms, nasopharyngeal neoplasms, therapeutics, enteral nutrition		Clin Transl Radiat Oncol20260
SPINAL: study protocol for a multicenter non-inferiority trial evaluating reduce vertebral irradiation volumes in palliative radiotherapy for spinal bone metastases on analgesic efficacy.
PMID 42032485 — radiotherapy, neoplasms, neoplasm metastasis, analgesics, spine		BMC Cancer20260
Practice-changing clinical trials in radiation oncology: A 2024-2025 literature synthesis.
PMID 42001736 — radiation oncology, therapeutics		Cancer Radiother20260
Postoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers: The STEREOPOSTOP-GORTEC 2017-03 Nonrandomized Clinical Trial.
PMID 41632122 — radiotherapy, cells, carcinoma, squamous cell, neoplasms, clinical medicine, necrosis, beds, therapeutics, non-randomized controlled trials as topic, mouth		JAMA Netw Open20250
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial.
PMID 41448222 — extranodal extension, radiotherapy, cells, disease-free survival, carcinoma, squamous cell, squamous cell carcinoma of head and neck, nivolumab, therapeutics		Lancet Top journal20251

Clinical Studies 32

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 11 Study Chair: 1 Study Director: 2

By phase:

N/A 15
Phase 3 11
Phase 2 5
Phase 1 1

By status:

Recruiting 13
Completed 10
Active not recruiting 3
Not yet recruiting 3
Unknown 3

By type:

Interventional 31
Observational 1

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 5
multicentric5to9 4
multicentricup10 14

Main Topics

Ongoing Clinical Trials

14 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of JNJ 90301900 in Combination with Concurrent Chemoradiation Therapy in LA HNSCC
2025-522914-22-00 — squamous cell carcinoma of head and neck, therapeutics		Phase 1Recruiting2026
Impact of Prophylactic Bone Radiation Therapy in Patients With Bone Metastases
NCT07733193 — radiotherapy, mortality, pain, neoplasm metastasis, morbidity, therapeutics, bone and bones		Phase 3Not yet recruiting2026
Stereotactic Radiotherapy for SPinal Metastases With Limited Extent of Epidural Disease
NCT07656883 — radiotherapy, quality of life, safety, spinal cord, radiosurgery, neoplasms, disease progression, neoplasm metastasis, spinal cord compression, therapeutics, spine, spinal canal, bone and bones		N/ANot yet recruiting2026
A Phase 3 study of NBTXR3 with or without cetuximab in LA HNSCC
2024-520386-31-00 — radiotherapy, cells, cetuximab, carcinoma, squamous cell, drug therapy, aged, squamous cell carcinoma of head and neck, chemotherapy, carcinoma, head, neck		Phase 3Recruiting2025
First line immunotherapy based standard of care and local ablative treatments for oligometastatic non small cell lung cancer patients a randomized multicentre open label phase III study (OliGRAIL)
2023-503326-39-00 — cells, lung, neoplasms, carcinoma, non-small-cell lung, immunotherapy, lung neoplasms, small cell lung carcinoma, therapeutics		Phase 3Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS